SpringWorks Therapeutics Inc. (SWTX) Appoints Carlos Alban to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/17/2026

1. VRNS
2. JBHT
3. CRWV
4. TSLA
5. SCHW
6. GPRK
7. TFC
8. TRV
9. USB
10. SPY

Go back to SpringWorks Therapeutics Inc. (SWTX) Appoints Carlos Alban to its Board

SpringWorks Therapeutics Appoints Carlos Albán to its Board of Directors

July 15, 2022 6:30 AM EDT

STAMFORD, Conn., July 15, 2022 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced the appointment of Carlos Albán to the Companys Board of Directors. Mr. Albán, who served as Vice Chairman and Chief Commercial Officer at AbbVie, Inc. (AbbVie) until his retirement last year, brings over 30 years of experience in global commercial strategy and operations.

Carlos success in building and leading global commercial organizations will be valuable as SpringWorks continues its planned transition... More